The impact of air pollution on liver disease and cancer disparities
Air pollution and health disparities in liver disease and cancer
This study looks at how air pollution, especially tiny particles in the air, might increase the chances of liver disease and liver cancer in different racial and ethnic groups, hoping to find important connections that can help improve health and reduce risks for everyone.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10842425 on NIH RePORTER |
What this research studies
This research investigates how exposure to air pollution, specifically fine particulate matter, affects the risk of liver disease and liver cancer, particularly among different racial and ethnic groups. The project utilizes advanced geospatial science techniques to analyze health data and identify patterns of health disparities related to environmental factors. By focusing on nonalcoholic fatty liver disease and hepatocellular carcinoma, the research aims to uncover critical links between environmental exposures and health outcomes. The findings could inform public health strategies and interventions to reduce these risks.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for liver disease or cancer, particularly those living in areas with high levels of air pollution.
Not a fit: Patients who do not have liver disease or cancer and are not exposed to significant air pollution may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and prevention strategies for liver disease and cancer, particularly in vulnerable populations affected by air pollution.
How similar studies have performed: Previous research has indicated a correlation between air pollution and various health outcomes, suggesting that this approach may yield valuable insights into liver disease and cancer disparities.
Where this research is happening
Seattle, United States
- Fred Hutchinson Cancer Center — Seattle, United States (Active)
Researchers
- Principal investigator: Vopham, Trang — Fred Hutchinson Cancer Center
- Study coordinator: Vopham, Trang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.